Genetic profiling helps patients with rare cancers receive matched treatments

Genetic profiling is feasible in patients with rare cancers, with more than half having actionable findings that may lead to treatment with a drug matched to the biomarker, according to an Australian study. Results from the NOMINATOR (GeNOmic MatchINg TreATment fOr Rare Cancers) study were presented at the COSA 2020 virtual meeting by Dr Damien ...

Already a member?

Login to keep reading.

© 2022 the limbic